Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MaxCyte Inc (MXCT)
NASDAQ:MXCT
Holding MXCT?
Track your performance easily
Earnings Data
Report Date
Apr 23, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 24, 2019
|% Change Since: 19.59%
|Next Earnings Date:Sep 24, 2018
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive sentiment with strong core revenue growth, a record number of SPLs signed, and positive market trends in cell and gene therapy. However, challenges such as a decline in gross margin due to a one-time write-off, a decline in drug discovery revenue, and a cautious spending environment are notable lowlights.Company Guidance
During the call, MaxCyte provided key financial metrics, reporting total revenue of $8.2 million for the third quarter of 2024, a slight increase from $8 million in the same period last year, which translates to a 2% growth. Core revenue increased by 23% to $8.1 million, driven by a 39% rise in revenue from cell therapy customers, reaching $6.5 million. Instrument revenue was stable at $1.8 million, while lease revenue remained consistent at $2.5 million. Processing Assembly (PA) revenue grew significantly by 54% year-over-year to $3.4 million. The company also highlighted the signing of six new Strategic Platform Licenses (SPLs) in 2024, bringing the total to 29, a record for the company. MaxCyte increased its core revenue growth guidance for 2024 to at least 5% and reiterated its SPL Program-related revenue outlook of approximately $6 million for the year. They also ended the third quarter with $196.6 million in cash and no debt, raising their year-end cash expectations to $185 million.Record Number of Strategic Platform Licenses (SPLs) Signed
MaxCyte signed six new Strategic Platform Licenses in 2024, including one in the third quarter, setting a record for the company.
Strong Core Revenue Performance
Core revenue increased by 23% year-over-year, with cell therapy customers contributing $6.5 million, a 39% increase from the prior year.
Significant Growth in Processing Assembly (PA) Revenue
PA revenue was $3.4 million, growing 54% year-over-year, driven by broad-based customer demand.
Positive Progress in Cell and Gene Therapy Market
MaxCyte continues to see growth in non-viral cell therapies and complex therapies requiring multiple engineering steps.
Optimistic Outlook for SPL Pipeline
Strong pipeline execution with six SPLs signed in 2024 and ongoing optimism for future customer impact.
Promotion of Key Leadership
Ali Soleymannezhad promoted to Chief Commercial Officer and Jeremy Kolenbrander hired as Head of Engineering, strengthening commercial and product development efforts.
---
MXCT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MXCT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $3.88 | $3.46 | -10.82% |
| Aug 06, 2024 | $4.45 | $4.08 | -8.31% |
| May 07, 2024 | $3.93 | $4.64 | +18.07% |
| Mar 12, 2024 | $3.98 | $4.16 | +4.52% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does MaxCyte Inc (MXCT) report earnings?
MaxCyte Inc (MXCT) is schdueled to report earning on Apr 23, 2025, TBA Not Confirmed.
What is MaxCyte Inc (MXCT) earnings time?
MaxCyte Inc (MXCT) earnings time is at Apr 23, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MXCT EPS forecast?
Currently, no data Available
---